SES
The Luxembourg Directorate of Defence (DoD) procured two ground stations following a competitive call for tender to enable the Luxembourg Army to improve its resilience by accessing secure satellite communications services, the DoD, SES and HITEC Luxembourg said today.
The ground stations, which will be installed at the Luxembourg Army’s Military Centre in Diekirch, will be used for Luxembourg’s GovSat-1 satellite services in X- and Military Ka-band frequencies, as well as for the Wideband Global Satcom (WGS) system, the backbone of the satellite communications capability of the U.S. DoD.
The addition of the two new ground stations reinforce resiliency and augment the existing Luxembourg Army satcom infrastructure already built by SES and HITEC Luxembourg 10 years ago, bringing the total number of dedicated antennas to four. The new ground stations unlock the strong potential to scale and add interoperability with the NATO partner systems, in line with the country’s defence strategy for the years to come.
Yuriko Backes, Luxembourg Minister of Defence: “Access to secure satellite communications has always been among the priorities and strengths of Luxembourg, allowing the country to reinforce defence capabilities, as well as enabling fulfillment of Luxembourg’s commitments towards the EU and NATO. To keep the upper technological edge, we will continue to leverage Luxembourg’s globally-renowned expertise in the space sector, to increase our resilience, including that of our armed forces.”
“It is an honour for SES to help strengthen the Luxembourg Government’s defence pillar by adding resiliency to its secure satcom,” said Adel Al-Saleh, CEO of SES. “Following the successful implementation of the initial ground stations by the Luxembourg Army, we are delighted to extend its communications infrastructure that leverages Luxembourg’s GovSat-1 and enhances interoperability with the partner systems.”
“We are proud to be part of the project and once again join efforts with SES to help augment Luxembourg’s defence capabilities with resilient and proven technology,” said Philippe Osch, CEO of HITEC Luxembourg. “The ground terminals to be supplied for the Luxembourg Army’s satcom infrastructure are a source of particular pride for us as they combine the latest technological innovations and a track-record of superior “Made in Luxembourg” quality.”
Follow us on:
Twitter | Facebook | YouTube | LinkedIn | Instagram
About SES
SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless data connectivity services around the world. As a leader in global content connectivity solutions, SES owns and operates the world’s only geosynchronous orbit and medium earth orbit (GEO-MEO) constellation of satellites with the unique combination of global coverage and high performance. By leveraging its vast and intelligent, cloud-enabled network, SES delivers high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries over 6,400 channels, reaching 369 million households, delivering managed media services for both linear and non-linear content. The company is headquartered in Luxembourg and listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com
About HITEC Luxembourg
HITEC Luxembourg S.A., a 100%-owned Luxembourg company, has developed its business activities in the field of innovative and quality products and services.
HITEC offers high technology solutions covering different business areas: satellite ground segment; specific and standard equipment for testing and measuring of physical properties; traffic management; mission critical; engineering; consulting; software & ICT development and project management. HITEC serves private and public sector customers at a national and international level.
In our daily commitment, know-how, creativity, quality and perseverance are an integral part of HITECs’ undertaking. Enthusiasm for technology and innovation and a dedication to life-long-learning are core elements of our company culture, reflected by our highly qualified and motivated staff.
HITEC is ISO 9001, ISO 14001, ISO 45001 and AQAP 2110 certified and has several labels, such as “SuperDrecksKëscht fir Betriber“ (ISO 14024:2000 Standard), “Entreprise Socialement Responsable”, delivered by the indr, Responsibility Europe, Made in Luxembourg (for most of the products & services) and is signatory of the IMS Diversity Charter and the “Pacte National – Entreprises et Droits de l’Homme Luxembourg”. HITECs’ motto: market-oriented, client-centric and technology driven.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240222299678/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vonage Network APIs Pave the Way for Freenow by Lyft to Advance Urban Mobility Innovation22.1.2026 08:00:00 CET | Press release
Freenow adopts Vonage APIs to access network capabilities, strengthening fraud prevention through faster, verified connections with drivers for millions of riders Vonage, a part of Ericsson, and Freenow by Lyft, a leading taxi and multi-mobility app in Europe, have expanded their partnership with the launch of Vonage Silent Authentication API for customers based in the U.S. Vonage Network APIs enable Freenow by Lyft to tap into real-time network data and insights, helping prevent fraud through seamless user verification, ensuring reliable, efficient, and secure interactions for its customers and drivers. Network intelligence is becoming a critical layer of defense in the transportation space as fraud threats become more sophisticated and targeted. Enterprises worldwide lost 7.7% of their annual revenue on average due to fraud over the past year, representing an estimated $534 billion in losses.¹ With scam/authorization fraud, synthetic identity fraud, and account takeover as the leadin
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe22.1.2026 07:30:00 CET | Press release
Daiichi Sankyo (TSE:4568) has appointed Veronika Rozehnal, Ph.D., to succeed Jürgen Müller, Ph.D., as the Head of the Translational Research Center Europe. Dr. Jürgen Müller will retire after nearly 30 years of research work at Daiichi Sankyo. Under his leadership, the Translational Research Center Europe, previously called the Tissue and Cell Research Center Munich, has grown from three to 40 researchers since it was founded in 1997 and has become an internationally recognized institution that plays a strategic role in the global innovation process of Daiichi Sankyo. Dr. Veronika Rozehnal joined Daiichi Sankyo in 2009 and has held various positions at the Translational Research Center Europe in addition to spending three years at the Daiichi Sankyo R&D Center in Tokyo. Dr. Rozehnal graduated from Ernst-Moritz-Arndt University of Greifswald, Germany with a Ph.D. degree in Clinical Pharmacology. “Jürgen Müller has made significant scientific contributions that have helped Daiichi Sankyo
Azafaros Announces Key Scientific Oral and Poster Presentations on Nizubaglustat Accepted for WORLDSymposium™ 202622.1.2026 07:00:00 CET | Press release
Five presentations will showcase nizubaglustat’s therapeutic potential in Lysosomal Storage Disorders. Nizubaglustat is currently being tested in two global Phase 3 studies for Niemann-Pick type C disease and GM1/GM2 gangliosidoses which are currently recruiting. Azafaros will host a satellite symposium on nizubaglustat on Day 2 of the symposium discussing the Phase 3 studies. WORLDSymposium™ 2026 takes place from February 2 to 6 in San Diego, California. Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that its lead asset, nizubaglustat, will feature in five scientific presentations accepted at the WORLDSymposium™ 2026, the leading global conference on lysosomal diseases, taking place in San Diego, California, USA between February 2-6. The company’s conference activities include: Oral Presentations (including Poster numbers 134 and 29-C) Long-term data from a Phase II study wit
I Squared Announces Launch of Radiant Energy Solutions22.1.2026 07:00:00 CET | Press release
I Squared Capital (“I Squared”), a leading global infrastructure investment manager, announced today the launch of Radiant Energy Solutions (“Radiant”), an investment from I Squared’s Middle East infrastructure strategy, which is focused on targeting transformational, mid-market investments in the region. Reflecting I Squared’s platform-building approach of starting with a core initial investment and scaling over time to build market-leading businesses, Radiant marks the firm’s entry into the Middle East distributed renewables market, providing decarbonization solutions to commercial and industrial customers. The investment for Radiant is the acquisition of FAS Renewables and its 100% owned subsidiary Zahra Energy, a Saudi Arabia–based distributed solar company with a secured and advanced portfolio of over 100MWp of distributed solar projects with established customers and long-term contracted solar power purchase agreements. These include Cenomi Centers, an owner, operator, and develo
IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio22.1.2026 07:00:00 CET | Press release
At IMCAS 2026, Galderma will present findings supporting Sculptra’s® regenerative properties and benefits on the body, including improving cellulite appearance, firmness, lift, projection, and contouring following its European Union (EU) Medical Device Regulation (MDR) certification, expanding its use to four body areas1-7 Multiple studies will reinforce the safety and efficacy of Galderma’s hyaluronic acid (HA) treatments range, including post-marketing data on Restylane® Shaype™ in shaping the chin, Restylane Lyft™ in improving jawline definition, Restylane Skinboosters™ in smoothing fine lines and wrinkles in the décolletage and Restylane Volyme™ in correcting hollowing of the temples8-11 New data on the innovative neuromodulator Relfydess™ (RelabotulinumtoxinA) will reinforce its rapid onset as early as Day 1 and sustained efficacy through six months for frown lines and crow’s feet12 As a leader in injectable aesthetic innovation, Galderma will showcase its superior science and edu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom